Parabens: A review of epidemiology, structure, allergenicity, and hormonal properties

Dermatitis

Volumn 16, Issue 2, 2005, Pages 57-66

  Cashman, Allison L ^a   Warshaw, Erin M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 HYDROXYBENZOIC ACID ESTER; ANILINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZOCAINE; BENZYL PARABEN; BUTACAINE; BUTETHAMINE; BUTYL PARABEN; CHLOROPROCAINE; CORTICOSTEROID; COSMETIC; DIURETIC AGENT; ETHYL PARABEN; HALOPERIDOL; HEPARIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INSULIN; LOCAL ANESTHETIC AGENT; METHYL PARABEN; PHENACAINE; PRESERVATIVE; PRILOCAINE; PROPYL PARABEN; RADIOPHARMACEUTICAL AGENT; TETRACAINE; UNINDEXED DRUG; VITAMIN;

ALLERGENICITY; ALLERGY; ANGIONEUROTIC EDEMA; ANTIMICROBIAL ACTIVITY; BRONCHOSPASM; CLINICAL TRIAL; DELAYED HYPERSENSITIVITY; DERMATITIS; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; EPIDEMIOLOGICAL DATA; HORMONE ACTION; HUMAN; HYPOTHESIS; METABOLISM; PATCH TEST; PRIORITY JOURNAL; PRURITUS; REVIEW; SAFETY; STRUCTURE ANALYSIS;

EID: 22544448088     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.1097/01206501-200506000-00001     Document Type: Review

References (129)

1. Richardson EL. Up-date frequency of preservative use in cosmetic formulas as disclosed to FDA. Cosmetic and Toiletries, FDA Report 1977;92:85.
2. Menne T, Hjorth N. Routine patch testing with paraben esters. Contact Dermatitis 1988;19:189-91.
3. Maddox DN. The role of p-hydroxybenzoates in modern cosmetics. Cosmetic Toiletries, FDA Report 1982;97:85-8.
4. Fukahori M, Akatsu S, Sato H, Yotsuyanagi T. Relationship between uptake of p-hydroxybenzoic acid esters by Escherichia coli and antibacterial activity. Chem Pharm Bull Tokyo 1996; 44:1567-70.
5. Kang SH, Kim H. Simultaneous determination of methylparaben, propylparaben and thimerosal by high-performance liquid chromatography and electrochemical detection. J Pharm Biomed Anal 1997;15:1359-63.
6. Fisher AA. Esoteric contact dermatitis. Part 1: The paraben paradox. Cutis 1996;57:65-6.
7. Lorenzetti OJ, Wernet TC. Topical parabens: benefits and risks. Dermatologica 1977;154:244-50.
8. Sasseville D. Hypersensitivity to preservatives. Dermatol Ther 2004;17:251-63.
9. Rastogi SC, Schouten A, Kruij FN, Weijland JW. Contents of methyl-, ethyl-, propyl-, butyl- and benzylparaben in cosmetic products. Contact Dermatitis 1995;32:28-30.
10. Elder RL. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J Am Coll Toxicol 1984;3:147-209.
11. Mowad CM. Allergic contact dermatitis caused by parabens: two case reports and a review. Am J Contact Dermat 2000;11:53-5.
12. Fransway AF. The problems of preservation in the 1990s. II. Agents with preservative function independent of formaldehyde release. Am J Contact Dermat 1991;2:145-74.
13. Bergfeld W, Belsito D, Marks J Jr, Andersen F. Safety of ingredients used in cosmetics. J Am Acad Dermatol 2005;52:125-32.
14. Oishi S. Lack of spermatotoxic effects of methyl and ethyl esters of p-hydroxybenzoic acid in rats. Food Chem Toxicol 2004;42: 1845-9.
15. Twist JN, Zats JL. Influence of solvents on parabens permeation through idealized skin model membranes. J Soc Cosmet Chem 1986;37:429-44.
16. Lee CH, Kim HJ. A study on the absorption mechanisms of drug through membranes. Arch Pharm Res 1994;17:182-9.
17. Soni MG, Burdock GA, Taylor SL, Greenberg NA. Safety assessment of propyl paraben: a review of the published literature. Food Chem Toxicol 2001;39:513-2.
18. Rietschel RL, Fowler JF Jr. Dermatitis to preservatives and other additives in cosmetics and medications. In: Rietschel RL, Fowler JF Jr, editors. Fisher's contact dermatitis. 4th ed. Philadelphia: Williams & Wilkins; 1995. p. 266-7.
19. Soni MG, Taylor SL, Greenberg NA, Burdock GA. Evaluation of the health aspects of methyl paraben: a review of the published literature. Food Chem Toxicol 2002;40:1335-73.
20. Schubert H, Baumbach N, Prater E, et al. Patch testing with parabens. Contact Dermatitis 1990;23:245-6.
21. Komatsu H. Percutaneous absorption of butyl paraben in vitro. II. Effects of micellar trapping of drug and percutaneous absorption of nonionic surfactants. Chem Pharm Bull 1984;32: 3739-43.
22. Esposito E, Bortolotti F, Nastruzzi C, et al. Diffusion of preservatives from topical dosage forms: a comparative study. J Cosmet Sci 2003;54:239-50.
23. Han J, Washington C. Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability. Int J Pharm 2005;288:263-71.
24. Lobemeier C, Tschoetschel C, Westie S, Heymann E. Hydrolysis of parabens by extracts from differing layers of human skin. Biol Chem 1996;377:647-51.
25. Nakazawa H, Oda H, Fujisima H, et al. [Analysis of chlorobenzenes, para-hydroxybenzoic acid esters and herbicide in human subjects using GC/MS.] A report of the Research Fund of Health and Welfare of Japan. Tokyo: Ministry of Health and Welfare of Japan; 1999. p. 16.
26. Rietschel RL, Fowler JF Jr. Allergy to preservatives and vehicles in cosmetics and toiletries. In: Rietschel RL, Fowler JF Jr, editors. Fisher's contact dermatitis. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 211-59.
27. Sokoloski WT, Chidester CG, Honeywell GE. The hydrolysis of methyl p-hydroxybenzoate by Cladosporium resinae. Dev Ind Microbiol 1962;3:179-87.
28. Hugo WB, Foster JHS. Growth of Pseudomonas aeruginosa in solutions of esters of p-hydroxybenzoic acid. J Pharm Pharmacol 1964;16:209.
29. Close JA, Neilsen PA. Resistance of a strain of Pseudomonas cepacia to esters of p-hydroxybenzoic acid. Appl Environ Microbiol 1976;31:718-22.
30. Bertani I, Kojic M, Venturi V. Regulation of p-hydroxybenzoic acid hydroxylase gene. Microbiology 2001;147:1611-20.
31. Valkova N, Lepine F, Labrio L, et al. Purification and characterization of PrbA, a new esterase from Enterobacter cloacae hydrolyzing the esters of 4-hydroxybenzoic acid (parabens). J Biol Chem 2003;278:12779-85.
32. Kok RG, D'Argenio DA, Ornston LN. Mutation analysis of PobR and PcaU, closely related transcription activation in Acinetobacter. J Bacteriol 1998;180:5058-69.
33. Hutchinson J, Runge W, Mulvey M, et al. Burkholderia cepacia infections associated with intrinsically contaminated ultrasound gel: the role of microbial degradation of parabens. Infect Control Hosp Epidemiol 2004;25:291-6.
34. Valkova N, Lepine F, Valeanu L, et al. Hydrolysis of 4-hydroxybenzoic acid esters (parabens) and their aerobic transformation into phenol by the resistant Enterobacter cloacae strain EM. Appl Environ Microbiol 2001;67:2404-9.
35. Valkova N, Lepine F, Bollet C, et al. PrM, a gene coding for an esterase hydrolyzing parabens in Enterobacter cloacae and Enterobacter gergoviae strains. J Bacteriol 2002;184:5011-7.
36. Tresoldi AT, Padoveze MC, Trabasso P, et al. Enterobacter cloacae sepsis outbreak in a newborn unit caused by contaminated total parenteral nutrition solution. Am J Infect Control 2000;28:258-61.
37. Archibald LK, Ramos M, Arduino MJ, et al. Enterobacter cloacae and Pseudomonas aerugnosa polymicrobial bloodstream infections traced to extrinsic contamination of a dextrose multidose vial. J Pediatr 1998;133:640-4.
38. Wang SA, Levine RB, Carson LA, et al. An outbreak of gram-negative bacteremia in hemodialysis patients traced to hemodialysis machine waste drain ports. Infect Control Hosp Epidemiol 1999;20:746-51.
39. Bonnevie P. Overfolsomhed for aetylparauxybenzoat (Mycocten). Nord Med 1940;6:684-6.
40. Menne T, Hjorth N. Routine patch testing with paraben esters. Contact Dermatitis 1988;19:189-91.
41. Krob HA, Fleischer AB Jr, D'Agostino R Jr, et al. Prevalence and relevance of contact dermatitis allergens: a meta-analysis of 15 years of published T.R.U.E. test data. J Am Acad Dermatol 2004;51:349-53.
42. Fregert S, Hjorth N, Magnusson B, et al. Epidemiology of contact dermatitis. Trans St Johns Hosp Derm Soc 1969;55:17-35.
43. Bandmann HJ, Cronin E, Hjorth N, et al. Dermatitis from applied medicaments. Arch Dermatol 1972;106:335-7.
44. Burry JN, Kirk J, Reid JG, et al. Environmental dermatitis: patch tests in 1,000 cases of allergic contact dermatitis. Med J Aust 1973; 2:681-5.
45. Marsulli FN, Maibach HI. Status of topical parabens: skin hypersensitivity. Int J Dermatol 1974;13:397-9.
46. Brun R. Epidemiology of contact dermatitis in Geneva (1000 cases). Contact Dermatitis 1975;1:214-7.
47. Rudner EJ, Clendenning WE, Epstein E, et al. The frequency of contact sensitivity in North America 1972. Contact Dermatitis 1975;1:277-80.
48. Rudner EJ. North American Group results. Contact Dermatitis 1977;3:208-9.
49. Lepine EM. Results of routine office patch testing. Contact Dermatitis 1976;2:89-91.
50. Husain SL. Contact dermatitis in the west of Scotland. Contact Dermatitis 1977;3:327-32.
51. Camarasa JNG. First epidemiological study of contact dermatitis in Spain-1977. Acta Derm Venereol Suppl (Stockh) 1979;59:33-7.
52. Calas E, Castelain PY, Piriou A. Epidemiologie des dermatoses de contact a Marseille. Ann Dermatol Venereol 1978;105:345-7.
53. Blondeel A, Oleffe J, Achten G. Contact allergy in 330 dermatological patients. Contact Dermatitis 1978;4:270-6.
54. Lynde CW, Warshawski L, Mitchell JC. Screening patch tests in 4190 eczema patients 1972-1981. NACDG patch test results for 1979-1980. Contact Dermatitis 1982;8:417-21.
55. Romaguera C, Grimalt F. Statistical and comparative study of 4600 patients tested in Barcelona (1973-1977). Contact Dermatitis 1980;6:309-15.
56. Edman B, Moller H. Trends and forecasts for standard allergens in a 12-year patch test material. Contact Dermatitis 1982;8:95-104.
57. de Groot AC, Weyland JW, Bos JD, Jagtman BA. Contact allergy to preservatives (I). Contact Dermatitis 1986;14:120-2.
58. de Groot AC, Bos JD, Jagtman BA, et al. Contact allergy to preservatives-II. Contact Dermatitis 1986;15:218-22.
59. Vestey JP, Gawkrodger DJ, Wong WK, et al. An analysis of 501 consecutive contact clinic consultations. Contact Dermatitis 1986;15:119-25.
60. Broeckx W, Blondeel A, Dooms-Goosens A, et al. Cosmetic intolerance. Contact Dermatitis 1987;16:189-94.
61. Gollhausen R, Enders F, Przybilla B, et al. Trends in allergic contact sensitization. Contact Dermatitis 1988;18:147-54.
62. Hogan DJ, Hill M, Lane PR. Results of routine patch testing of 542 patients in Saskatoon, Canada. Contact Dermatitis 1988; 19:120-4.
63. Enders F, Przybilla B, Ring J, Gollhausen R. Patch test results in 1987 compared to trends from the period 1977-1983. Contact Dermatitis 1989;20:230-2.
64. Macfarlane AW, Curley RK, Graham RM, et al. Sensitivity to various ingredients of topical preparations following prolonged use. Contact Dermatitis 1990;23:367-8.
65. George MD, Srinivas CR, Balachandran C, et al. Sensitivity to various ingredients of topical preparations following prolonged use. Contact Dermatitis 1990;23:367-8.
66. Seidenari S, Manzini BM, Danese P, et al. Patch and prick test study of 593 healthy subjects. Contact Dermatitis 1990;23:162-7.
67. Shehade SA, Beck MH, Millier VF. Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis 1991;24:119-22.
68. Marks JG Jr, DeLeo VA. Standard allergens. In: Marks JG, DeLeo VA, editors. Contact and occupational dermatology. Philadelphia: Mosby; 1997. p. 115-7.
69. Perrenoud D, Bricher A, Hunziker T, et al. Frequency of sensitization to 13 common preservatives in Switzerland. Swiss Contact Dermatitis Research Group. Contact Dermatitis 1994;30:276-9.
70. Marks JG, Belsito DV, Deleo VA, et al. North American Contact Dermatitis Group patch test results for the detection of delayed hypersensitivity to topical allergens. J Am Acad Dermatol 1998; 38:911-8.
71. Schnuch A, Geier J, Uter W, Frosch PJ. Patch testing with preservatives, antimicrobials and industrial biocides. Results from a multicentre study. Br J Dermatol 1998;138:467-76.
72. Lestringant GG, Bener A, Sawaya M, et al. Allergic contact dermatitis in the United Arab Emirates. Int J Dermatol 1999;38:181-6.
73. Marks JG Jr, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1996-1998. Arch Dermatol 2000;136:272-3.
74. Marks JG Jr, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 1998-2000. Am J Contact Dermal 2003;14:59-62.
75. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch-test results, 2000-2002 study period. Dermatitis 2004;15(4):1-8.
76. Scanberg IL. Allergic contact dermatitis to methyl and propyl paraben. Arch Dermatol 1967;95:626-8.
77. Wiepper KD. Paraben contact dermatitis. JAMA 1967;202:579-81.
78. Schorr WF. Paraben allergy: a cause of intractable dermatitis. JAMA 1968;204:859-62.
79. Downs AM, Sansom JE, Simmons I. Let Rip: fun pot dermatitis. Contact Dermatitis 1998;38:234.
80. Simpson JR. Dermatitis due to parabens in cosmetic creams. Contact Dermatitis 1978;5:311-2.
81. Verhaeghe I, Dooms-Goossens A. Multiple sources of allergic contact dermatitis from parabens. Contact Dermatitis 1997;36:269-70.
82. Eguino P, Sanchez A, Agesta N, et al. Allergic contact dermatitis due to propylene glycol and parabens in an ultrasonic gel. Contact Dermatitis 2003;48:290.
83. Praditsuwan P, Taylor JS, Roenigk HH Jr. Allergy to Unna boots in four patients. J Am Acad Dermatol 1995;33:906-8.
84. Fisher AA. Paraben dermatitis due to a new medicated bandage: the "paraben paradox." Contact Dermatitis 1979;5:273-4.
85. Fisher AA. Allergic paraben and benzyl alcohol hypersensitivity relationship of the "delayed" and "immediate" varieties. Contact Dermatitis 1975;1:281-4.
86. Fisher AA. Dermatitis of the hands from food additives. Cutis 1982;30:304,308,312,318,414.
87. Foti C, Bonamonte D, Antelmi A, et al. Allergic contact dermatitis to condoms: description of a clinical case and analytical review of current literature. Immunopharmacol Immunotoxicol 2004;26:481-5.
88. Wilkinson JD, Shaw S, Andersen KE, et al. Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis 2002;46:207-10.
89. Davis KA, Guenther L, Wexler DM. Paraben sensitivity. Can J Dermatol 1992;4:198-201.
90. Machet L, Couhe C, Perrinaud A, et al. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975-2003 data. Br J Dermatol 2004;150:929.
91. Fisher AA. The paraben paradoxes. Cutis 1973;12:830-1.
92. Schorr WF. The skin and chemical additives to foods [letter]. Arch Dermatol 1972;105:131.
93. Rietschel RL, Fowler JF Jr. Contact dermatitis from food additives and dyes. In: Rietschel RL, Fowler JF Jr, editors. Fisher's contact dermatitis. 4th ed. Philadelphia: Williams & Wilkins; 1995. p. 676.
94. Kaminer Y, Apter A, Tyano S, et al. Delayed hypersensitivity reaction to orally administered methyl paraben. Clin Pharmacol 1982;1:469-70.
95. Veien NK, Hattel T, Laurberg G. Oral challenge with parabens in paraben-sensitive patients. Contact Dermatitis 1996;34:433.
96. Katsarou A, Armenaka M, Ale I, et al. Frequency of immediate reactions to the European standard series. Contact Dermatitis 1999;41:276-9.
97. Maibach HI, Johnson HL. Contact urticaria syndrome: contact urticaria to diethyltoluamide (immediate-type hypersensitivity). Arch Dermatol 1975;111:726-30.
98. Carr TW. Severe allergic reaction to an intraurethral lignocaine preparation containing paraben preservatives. Br J Urol 1990;66:98.
99. Henry JC, Tschen EH, Becker LE. Contact urticaria to parabens. Arch Dermatol 1979;115:1231-2.
100. Rietschel RL, Fowler JF Jr. Contact urticaria. In: Rietschel RL, Fowler JF Jr, editors. Fisher's contact dermatitis. 4th ed. Philadelphia: Williams & Wilkins; 1995. p. 792.
101. Kajimoto Y, Rosenberg ME, Kytta J, et al. Anaphylactoid skin reactions after intravenous regional anaesthesia using 0.5% prilocaine with or without preservative-a double-blind study. Acta Anaesthesiol Scand 1995;39:782-4.
102. Aldrete JA, Johnson DA. Allergy to local anesthetics. JAMA 1969; 20:356-7.
103. Latronica RJ, Goldberg AF, Wightman JR. Local anesthetic sensitivity: report of a case. Oral Surg 1969;28:439-41.
104. Nagel JE, Fuscaldo JT, Fireman P. Paraben allergy. JAMA 1977; 237:1594-5.
105. Fine PG, Dingman DL. Hypersensitivity dermatitis following suction-assisted lipectomy: a complication of local anesthetic. Ann Plast Surg 1988;20:573-5.
106. Johnson WT, DeStigter T. Hypersensitivity to procaine, tetracaine, mepivacaine, and methyl paraben: report of a case. J Am Dent Assoc 1983;106:53-6.
107. Luebke NH, Walker JA. Discussion of sensitivity to preservatives in anesthetics. J Am Dent Assoc 1978;97:656-7.
108. Swanson JG. Assessment of allergy to local anesthetic. Ann Emerg Med 1983;12:316-8.
109. Carradori S, Peluso AM, Faccioli M. Systemic contact dermatitis due to parabens. Contact Dermatitis 1990;22:238-9.
110. Aeling JL, Nuss DD. Systemic eczematous "contact type" dermatitis medicamentosa caused by parabens [letter]. Arch Dermatol 1974;110:640.
111. Sato K, Kazama JJ, Wada Y, et al. Hypersensitivity to paraoxybenzoic acid esters (parabens) in a dialysis patient. Nephron 2002; 92:728-9.
112. Bucks DA, McMaster JR, Maibach HI, Guy RH. Bioavailability of topically administered steroids: a "mass balance" technique. J Invest Dermatol 1988;91:29-33.
113. Hjorth N, Trolle-Lassen C. Skin reactions to ointment bases. Trans St Johns Hosp Dermatol Soc 1963;49:127-40.
114. Qiao GL, Riviere JE. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in-vivo in swine. J Pharm Sci 1995;84:425-32.
115. Potts RO. Stratum corneum hydration: experimental techniques and interpretation of results. J Soc Cosmet Chem 1986;37: 9-33.
116. Cross SE, Roberts MS. The effect of occlusion on epidermal penetration of parabens from a commercial allergy test ointment, acetone and ethanol vehicles. Soc Investig Dermatol 2000;115: 914-8.
117. Rudzki E, Kleniewska D. The epidemiology of contact dermatitis in Poland. Br J Dermatol 1970;83:543.
118. Routledge EJ, Parker J, Odum J, et al. Some alkyl hydroxyl benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998;153:12-9.
119. Lemini C, Silva G, Timossi C, et al. Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ Res 1997;75:130-4.
120. Blair RM, Fang H, Branham WS, et al. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 2000;54:138-53.
121. Hossaini A, Larsen JJ, Larsen JC. Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays. Food Chem Toxicol 2000;38:319-23.
122. Pedersen KL, Pedersen SN, Christiansen LB, et al. The preservatives ethyl-, propyl-, and butyl- paraben are estrogenic in an in vivo fish assay. Pharmacol Toxicol 2000;86:110-3.
123. Okubo T, Yokoyama Y, Kano K, Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR. Food Chem Toxicol 2001;39:1225-32.
124. Inui M, Adachi T, Takenaka S, et al. Effect of UV screens and preservatives on vitellogenin and choriogenin production in male medaka (Oryzias latipes). Toxicology 2003;194:43-50.
125. Darbre PO, Byford JR, Shaw LE, et al. Oestrogenic activity of benzyl paraben. J Appl Toxicol 2003;23:43-51.
126. Darbre PD. Underarm cosmetics and breast cancer. J Appl Toxicol 2003;23:89-95.
127. Darbre PD, Aljarrah A, Miller WR, et al. Concentrations of parabens in human breast tumours. J Appl Toxicol 2004;24:5-13.
128. Oishi S. Effects of butyl paraben on male reproductive system in rats. Toxicol Ind Health 2001;17:31-9.
129. Oishi S. Effects of butyl paraben on the male reproductive system in mice. Arch Toxicol 2002;76:423-9.